» Articles » PMID: 39113304

Handgrip Strength and Clinical Evolution of People Living with HIV: A Mini Narrative Review

Abstract

HIV infection is a worldwide epidemic. Antiretroviral therapy allows people living with HIV (PLHIV) increased longevity and a better quality of life. Among the various ways of monitoring the clinical evolution of PLHIV, handgrip strength (HGS) is a promising strategy, as this test can be used to assess the health condition quickly and at a low cost. In this sense, the present study aims to describe, through a literature review, the relationship between HGS and the clinical evolution of PLHIV, especially with morbimortality. Initially, it is highlighted that aging, HIV infection, and excess body fat are related to the loss of HGS in PLHIV. Furthermore, PLHIV is more likely to present cardiometabolic diseases that can be aggravated by reduced HGS. Thus, in people without positive HIV serology, low HGS indirectly, through the presence of risk factors or cardiometabolic diseases, or directly increases the chance of mortality. In conclusion, the lack of studies on this topic for PLHIV is highlighted, and more longitudinal studies, including control groups, are needed.

References
1.
Akbari M, Fararouei M, Haghdoost A, Gouya M, Kazerooni P . Survival and associated factors among people living with HIV/AIDS: A 30-year national survey in Iran. J Res Med Sci. 2019; 24:5. PMC: 6383342. DOI: 10.4103/jrms.JRMS_630_18. View

2.
Smith C, Ryom L, Weber R, Morlat P, Pradier C, Reiss P . Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration. Lancet. 2014; 384(9939):241-8. DOI: 10.1016/S0140-6736(14)60604-8. View

3.
Rava M, Dominguez-Dominguez L, Bisbal O, Lopez-Cortes L, Busca C, Antela A . Late presentation for HIV remains a major health issue in Spain: Results from a multicenter cohort study, 2004-2018. PLoS One. 2021; 16(4):e0249864. PMC: 8059864. DOI: 10.1371/journal.pone.0249864. View

4.
Maciel R, Kluck H, Durand M, Sprinz E . Comorbidity is more common and occurs earlier in persons living with HIV than in HIV-uninfected matched controls, aged 50 years and older: A cross-sectional study. Int J Infect Dis. 2018; 70:30-35. DOI: 10.1016/j.ijid.2018.02.009. View

5.
Zanetti H, Mendes E, Chagas A, Gomes Douglas M, Lopes L, Roever L . Triad of the Ischemic Cardiovascular Disease in People Living with HIV? Association Between Risk Factors, HIV Infection, and Use of Antiretroviral Therapy. Curr Atheroscler Rep. 2018; 20(6):30. DOI: 10.1007/s11883-018-0727-9. View